Delivery Order SPE2DB25D2204-SPE2DB25FTHBC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,382.19 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The product will be delivered to the company's facility...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.94 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This competitive, non-set-aside award represents a firm fixed-price delivery order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,318.60 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count units). The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, awarded on July 30, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg, a controlled-release medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $1,512.22, represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025. The order was fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.67 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count containers) with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price arrangement with a ceiling value of $1,297.75. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate ER 54 mg tablets in quantities of 100 units, valued at $1,279.09. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.04 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTHBCDelivery Order
The Defense Logistics Agency awarded a $1,719.57 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 54 mg, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, leverages its extensive IDC with DLA to fulfill federal medical procurement requirements across therapeutic domains ranging from specialty medications to vaccines and medical supplies. This particular delivery order for methylphenidate, a controlled substance commonly used in ADHD treatment, reflects the company's critical role in supplying essential pharmaceutical commodities to support Defense Health Agency and other federal healthcare systems. The contract demonstrates AmerisourceBergen's capacity to execute orders through open competition and manage the distribution of controlled medications as part of its federal medical supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/19/25 |